|
|
Volumn 195, Issue 1, 2001, Pages 75-77
|
|
Production of autologous keratinocytes for therapeutic purposes within a pharmaceutical company;Production de kératinocytes autologues à buts thérapeutiques au sein d'un établissement pharmaceutique.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
ANIMAL;
ARTIFICIAL SKIN;
AUTOTRANSPLANTATION;
BIOTECHNOLOGY;
BURN;
CELL CULTURE;
COCULTURE;
CULTURE TECHNIQUE;
CYTOLOGY;
DRUG INDUSTRY;
FIBROBLAST;
FORECASTING;
FRANCE;
HUMAN;
INJURY;
KERATINOCYTE;
METHODOLOGY;
MOUSE;
ORGANIZATION AND MANAGEMENT;
PLASTIC SURGERY;
PRESERVATION;
QUALITY CONTROL;
REVIEW;
TRANSPLANTATION;
ANIMALS;
BIOLOGICAL MARKERS;
BIOTECHNOLOGY;
BURNS;
CELL CULTURE TECHNIQUES;
CELLS, CULTURED;
COCULTURE TECHNIQUES;
DRUG INDUSTRY;
FIBROBLASTS;
FORECASTING;
FRANCE;
HUMANS;
KERATINOCYTES;
MICE;
PRESERVATION, BIOLOGICAL;
QUALITY CONTROL;
SKIN, ARTIFICIAL;
SURGERY, PLASTIC;
TRANSPLANTATION, AUTOLOGOUS;
WOUNDS AND INJURIES;
MLCS;
MLOWN;
|
|
EID: 17744411619
PISSN: 12950661
EISSN: None
Source Type: Journal
DOI: 10.1051/jbio/2001195010075 Document Type: Review |
|
Times cited : (4)
|
|
References (8)
|
